Brinkhuis, Francine
Julian, Elaine
van den Ham, Hendrika http://orcid.org/0000-0003-0513-0894
Gianfrate, Fabrizio
Strammiello, Valentina
Berntgen, Michael
Pavlovic, Mira
Mol, Peter http://orcid.org/0000-0002-4262-3180
Wasem, Jürgen
Van Dyck, Walter http://orcid.org/0000-0002-2829-3779
Cardone, Antonella http://orcid.org/0000-0003-3685-1512
Dierks, Christian
Schiel, Anja http://orcid.org/0000-0002-1258-4731
Bernardini, Renato
Solà-Morales, Oriol http://orcid.org/0000-0002-8312-8178
Ruof, Jörg
Goettsch, Wim
Funding for this research was provided by:
AbbVie
AstraZeneca
Pharmaceuticals Bayer
Novartis
F. Hoffmann-La Roche
Sanofi
Seagen
Article History
Received: 29 October 2023
Accepted: 20 May 2024
First Online: 2 July 2024
Declarations
: The views expressed in this article are the personal views of the author(s) and should not be interpreted or cited as representing the stance of the regulatory agency/agencies or organization(s) with which the author(s) is/are affiliated.
: Not applicable.
: Not applicable.
: J.R. and E.J. received an unrestricted grant from Abbvie, AstraZeneca, Bayer, Novartis, Roche, Sanofi and Seagen that partially funded this research. The authors have no further financial or non-financial interests to disclose.